There is evidence for two subpopulations among circulating endothelial progenitor cells (EPCs), i.e., CD34 + -EPCs and CD14 + -EPCs. Prior studies on the relationship between the level of EPCs and coronary artery disease (CAD), either did not distinguish between the two types of EPCs or studied only CD34 + -EPCs. We therefore investigated whether the number of circulating CD14 + -EPCs correlates with either CAD and/or cardiovascular risk factors. Circulating CD14 + -EPCs-as defined by the surface markers CD14 + KDR + -were analyzed by flow cytometry in 100 individuals [34 control subjects, 41 patients with stable CAD and 25 patients with acute coronary syndromes (ACS)]. The level of circulating CD14 + -EPCs was not significantly different in patients with normal coronary arteries compared to those with stable CAD or ACS. Neither was there any association between the severity of CAD or risk factors and the number of circulating CD14 + -EPCs. Thus, the number of circulating CD14 + -EPCs was not significantly correlated either with the severity of coronary disease or with cardiovascular risk factors.
Abnormal PCoAs (Types P-I and P-II) might be more vulnerable to PCoAA development, and Type P-II was the most vulnerable. There was a correlation between the angles of C7 and C6 part of the internal carotid artery and the presence of symptomatic PCoAA, with smaller angles being associated with increased frequency of symptomatic PCoAA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.